AI assistant
Advanced Enzyme Technologies Limited — Capital/Financing Update 2025
Mar 27, 2025
62369_rns_2025-03-27_5aecf993-90ad-4e1e-86aa-c02f6c364469.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
March 27, 2025
BSE Limited National Stock Exchange of India Limited P. J. Towers, Exchange Plaza, Plot No. C/1, Dalal Street, G Block, Bandra-Kurla Complex, Mumbai- 400 001 Bandra (E) Mumbai- 400 051 Scrip Code-540025 Trading Symbol-ADVENZYMES
Dear Sir,
Subject: Intimation for grant of stock Options under Advanced Enzyme Technologies Limited - Employees Stock Option Scheme 2022 (“the Scheme”) Ref: ISIN: INE837H01020
We wish to inform you that Nomination and Remuneration Committee of the Board of Directors of the Company vide Circular Resolution passed on March 27, 2025, has approved the grant of 5,12,500 stock Options under the Employees Stock Option Scheme 2022 (“the Scheme”).
In view of the aforesaid, enclosed is Annexure I indicating the details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 for the above mentioned ESOP Grant.
The aforesaid is also being uploaded on the website of the Company i.e. www.advancedenzymes.com
This is for your information and for public at large.
Thanking you, Yours faithfully, For Advanced Enzyme Technologies Limited
SANJAY Digitally signed by PRAKASH SANJAY PRAKASH BASANTA BASANTANI Date: 2025.03.27 NI 16:12:06 +05'30'
Sanjay Basantani Company Secretary and Head – Legal Encl.: As above
Annexure-1
Disclosure pursuant to SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024
For “AETL - Employees Stock Option Scheme 2022” [‘ Scheme’ ]
| Sr. No. |
Particulars |
Remarks |
|---|---|---|
| 1. | Brief details of Options granted |
5,12,500 Options granted by the Nomination & Remuneration Committee (vide Circular Resolution passed on March 27, 2025)to the Employees as defined under the Scheme. |
| 2. | Whether the scheme is in terms of SEBI (SBEB) Regulations,2021 |
Yes |
| 3. | Total number of shares covered by these options |
Stock Options granted under the aforesaid Grant covers 5,12,500 Equity Shares. 1 Option shall be entitled for conversion to only 1 Share of the Company, subject to the terms of the Scheme. |
| 4. | Pricing formula | As per the Scheme, the Exercise Price including method for arriving at it shall be determined by the Committee at the time of Grant, provided that the said Exercise Price shall not be higher than the prevailing Market Price (defined below) of the Shares discounted by minimum 33.33% (ceiling); as may be determined by the Committee based on the criteria specified in the Scheme, subject to the Applicable Law; and the Exercise Price per Option shall not be less than the then prevailing face value (₹2) of the Equity Shares of the Company. As regards the captioned grant of Options under Category II and Category III, the pricing formula determined by the Committee is as follows: Category II: Employees who have been granted Options upto 5,000 - First 500 Options at₹2/- each and remaining Options at the discount of 50% on the Market Price (as defined below) Category III: Employees who have been granted Options more than 5,000 - 500 Options at₹2/- each. The Exercise price for 4,500 Options shall be at the discount of 50% on the Market Price. For the remaining Options, the Exercise Price shall at the discount of 33.33% on the Market Price. Note: Exercise Price may be rounded-off as regards decimals, if any, within the Exercise Formula specified above read with clause 11 of the ESOP Scheme. |
| 5. | Options Vested | Not Applicable | |
| 6. | Time within which option may be exercised |
Exercise period shall not exceed 6 (six) months from relevant Vesting date and the date after which the Options shall lapse, unless the said period is extended by the Committee in exceptional circumstances. The Options shall not Vest for a period of one year from the date of Grant. Upon the expiry of one year, the Vesting of Options shall take place over a maximum term of fiveyears asper clause 14 of the Scheme. |
|
| 7. | Options exercised | Not Applicable | |
| 8. | Money realised by exercise of Options |
Not Applicable | |
| 9. | The total number of shares arising as a result of exercise of option |
Not Applicable | |
| 10. | Options lapsed | Not Applicable | |
| 11. | Variation of terms of options |
Not Applicable | |
| 12. | Brief details of significant terms |
With reference to the aforesaid Exercise Price/Scheme, the term "Market Price" means the average of Closing Price of the Equity Shares of the Company on the recognized Stock Exchange for last 90 (ninety) Trading Days preceding the date of Grant (which for the captioned case is March 27, 2025 – Grant Date) Explanation: If the Equity Shares of the Company are listed on more than one recognized Stock Exchange, then the Closing Price on the recognized Stock Exchange having higher trading volume, in aggregate is recorded for the said last 90 (ninety) Trading Days shall be considered for the purpose of determining the Market Price (which for the captioned Grant is NSE considering the trading volume for last 90 Trading Days). |
|
| 13. | Subsequent changes or cancellation or exercise of such options |
Not Applicable | |
| 14. | Diluted earnings per share pursuant to issue of equity shares on exercise of options. |
Not Applicable |